{"entity":{"type":"insider","cik":"0001697616","url":"/insider/0001697616","json_url":"/insider/0001697616.json","name":"Lucera Erick","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":10,"first":"2017-03-27","last":"2026-08-17","span_basis":"filed_date"},"name_variants":[{"name":"Lucera Erick","source":"filing","n_filings":10,"first_seen":"2017-03-27","last_seen":"2026-08-17"}],"transactions":[{"id":9295099,"accession":"0001697616-26-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001697616-26-000002","line_url":"/filing/0001697616-26-000002#line-1","is_derivative":false,"issuer_cik":"0001697616","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001697616","owner_cik":"0001697616","owner_name":"Lucera Erick","owner_display_name":"Lucera Erick","owner_url":"/insider/0001697616","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1797.0,"shares_display":"1,797","price_per_share":26.28,"price_display":"26.28","price_state":"stated","total_value":47225.16,"total_display":"47,225.16","total_whole":"47,225","shares_owned_after":119766.0,"shares_owned_after_display":"119,766","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-13","filed_date":"2026-08-17","scope":"insider"},{"id":6006182,"accession":"0001193125-26-285505","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-285505","line_url":"/filing/0001193125-26-285505#line-1","is_derivative":false,"issuer_cik":"0001697616","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001697616","owner_cik":"0001697616","owner_name":"Lucera Erick","owner_display_name":"Lucera Erick","owner_url":"/insider/0001697616","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2362.0,"shares_display":"2,362","price_per_share":20.37,"price_display":"20.37","price_state":"stated","total_value":48113.94,"total_display":"48,113.94","total_whole":"48,114","shares_owned_after":121563.0,"shares_owned_after_display":"121,563","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-25","filed_date":"2026-06-26","scope":"insider"},{"id":6177157,"accession":"0001193125-26-223961","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-223961","line_url":"/filing/0001193125-26-223961#line-1","is_derivative":false,"issuer_cik":"0001697616","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001697616","owner_cik":"0001697616","owner_name":"Lucera Erick","owner_display_name":"Lucera Erick","owner_url":"/insider/0001697616","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1448.0,"shares_display":"1,448","price_per_share":18.36,"price_display":"18.36","price_state":"stated","total_value":26585.28,"total_display":"26,585.28","total_whole":"26,585","shares_owned_after":123925.0,"shares_owned_after_display":"123,925","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-13","filed_date":"2026-05-14","scope":"insider"},{"id":5930034,"accession":"0001193125-26-142137","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-142137","line_url":"/filing/0001193125-26-142137#line-1","is_derivative":false,"issuer_cik":"0001697616","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001697616","owner_cik":"0001697616","owner_name":"Lucera Erick","owner_display_name":"Lucera Erick","owner_url":"/insider/0001697616","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5727.0,"shares_display":"5,727","price_per_share":18.64,"price_display":"18.64","price_state":"stated","total_value":106751.28,"total_display":"106,751.28","total_whole":"106,751","shares_owned_after":125373.0,"shares_owned_after_display":"125,373","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-01","filed_date":"2026-04-03","scope":"insider"},{"id":4930337,"accession":"0001650664-25-000027","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001650664-25-000027","line_url":"/filing/0001650664-25-000027#line-1","is_derivative":false,"issuer_cik":"0001650664","issuer_name":"Editas Medicine, Inc.","issuer_ticker":"EDIT","issuer_name_source":null,"issuer_url":"/issuer/0001650664","owner_cik":"0001697616","owner_name":"Lucera Erick","owner_display_name":"Lucera Erick","owner_url":"/insider/0001697616","role":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4109.0,"shares_display":"4,109","price_per_share":1.7108,"price_display":"1.71","price_state":"stated","total_value":7029.6772,"total_display":"7,029.68","total_whole":"7,030","shares_owned_after":112720.0,"shares_owned_after_display":"112,720","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-04","filed_date":"2025-03-05","scope":"insider"},{"id":2186066,"accession":"0001493152-24-032675","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-24-032675","line_url":"/filing/0001493152-24-032675#line-1","is_derivative":false,"issuer_cik":"0001641631","issuer_name":"Beyond Air, Inc.","issuer_ticker":"XAIR","issuer_name_source":null,"issuer_url":"/issuer/0001641631","owner_cik":"0001697616","owner_name":"Lucera Erick","owner_display_name":"Lucera Erick","owner_url":"/insider/0001697616","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":39266.0,"shares_display":"39,266","price_per_share":0.3964,"price_display":"0.40","price_state":"stated","total_value":15565.0424,"total_display":"15,565.04","total_whole":"15,565","shares_owned_after":43608.0,"shares_owned_after_display":"43,608","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-14","filed_date":"2024-08-15","scope":"insider"},{"id":3270107,"accession":"0001650664-24-000044","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001650664-24-000044","line_url":"/filing/0001650664-24-000044#line-1","is_derivative":false,"issuer_cik":"0001650664","issuer_name":"Editas Medicine, Inc.","issuer_ticker":"EDIT","issuer_name_source":null,"issuer_url":"/issuer/0001650664","owner_cik":"0001697616","owner_name":"Lucera Erick","owner_display_name":"Lucera Erick","owner_url":"/insider/0001697616","role":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22337.0,"shares_display":"22,337","price_per_share":5.6142,"price_display":"5.61","price_state":"stated","total_value":125404.3854,"total_display":"125,404.39","total_whole":"125,404","shares_owned_after":116829.0,"shares_owned_after_display":"116,829","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-20","filed_date":"2024-05-22","scope":"insider"},{"id":8367332,"accession":"0001493152-23-008245","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-23-008245","line_url":"/filing/0001493152-23-008245#line-1","is_derivative":false,"issuer_cik":"0001641631","issuer_name":"Beyond Air, Inc.","issuer_ticker":"XAIR","issuer_name_source":null,"issuer_url":"/issuer/0001641631","owner_cik":"0001697616","owner_name":"Lucera Erick","owner_display_name":"Lucera Erick","owner_url":"/insider/0001697616","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":6.817,"price_display":"6.82","price_state":"stated","total_value":13634.0,"total_display":"13,634.00","total_whole":"13,634","shares_owned_after":4342.0,"shares_owned_after_display":"4,342","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-16","filed_date":"2023-03-20","scope":"insider"},{"id":5317315,"accession":"0001697616-17-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001697616-17-000002","line_url":"/filing/0001697616-17-000002","is_derivative":false,"issuer_cik":"0001619250","issuer_name":"Valeritas Holdings Inc.","issuer_ticker":"VLRX","issuer_name_source":null,"issuer_url":"/issuer/0001619250","owner_cik":"0001697616","owner_name":"Lucera Erick","owner_display_name":"Lucera Erick","owner_url":"/insider/0001697616","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500.0,"shares_display":"1,500","price_per_share":4.95,"price_display":"4.95","price_state":"stated","total_value":7425.0,"total_display":"7,425.00","total_whole":"7,425","shares_owned_after":4000.0,"shares_owned_after_display":"4,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-22","filed_date":"2017-05-23","scope":"insider","n_lines":2},{"id":5151861,"accession":"0000899243-17-008671","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-008671","line_url":"/filing/0000899243-17-008671#line-1","is_derivative":false,"issuer_cik":"0001619250","issuer_name":"Valeritas Holdings Inc.","issuer_ticker":"VLRX","issuer_name_source":null,"issuer_url":"/issuer/0001619250","owner_cik":"0001697616","owner_name":"Lucera Erick","owner_display_name":"Lucera Erick","owner_url":"/insider/0001697616","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":30000.0,"total_display":"30,000.00","total_whole":"30,000","shares_owned_after":3000.0,"shares_owned_after_display":"3,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-23","filed_date":"2017-03-27","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":5,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001818794","name":"Dyne Therapeutics, Inc.","url":"/issuer/0001818794","role":"Officer (Chief Financial Officer)","n_filings":4,"first_seen":"2026-04-03","last_seen":"2026-08-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001650664","name":"Editas Medicine, Inc.","url":"/issuer/0001650664","role":"Officer (EVP, CHIEF FINANCIAL OFFICER)","n_filings":2,"first_seen":"2024-05-22","last_seen":"2025-03-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001641631","name":"Beyond Air, Inc.","url":"/issuer/0001641631","role":"Director","n_filings":2,"first_seen":"2023-03-20","last_seen":"2024-08-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001619250","name":"Valeritas Holdings Inc.","url":"/issuer/0001619250","role":"Officer","n_filings":2,"first_seen":"2017-03-27","last_seen":"2017-05-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001697616","retrieved_at":"2026-08-25T10:21:55+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}